SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 309,576.19 |
Enterprise Value ($M) | 324,619.99 |
Book Value ($M) | 10,165.90 |
Book Value / Share | 11.27 |
Price / Book | 30.45 |
NCAV ($M) | -20,679.90 |
NCAV / Share | -22.93 |
Price / NCAV | -14.97 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.23 |
Return on Assets (ROA) | 0.13 |
Return on Equity (ROE) | 0.68 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.80 |
Current Ratio | 1.05 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 18,034.50 |
Assets | 49,489.80 |
Liabilities | 38,714.40 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 28,541.40 |
Operating Income | 8,280.40 |
Net Income | 6,244.80 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 7,084.40 |
Cash from Investing | -3,261.60 |
Cash from Financing | -5,406.70 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Pnc Financial Services Group, Inc. | 5.25 | -0.11 | |
13G/A | Vanguard Group Inc | 7.73 | 6.02 | |
13G/A | BlackRock Inc. | 6.90 | 2.49 | |
13G/A | Lilly Endowment Inc | 10.83 | -4.20 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
339,604 | 1,979,155 | 17.16 | |
326,075 | 1,678,617 | 19.43 | |
421,885 | 2,107,123 | 20.02 | |
326,922 | 1,856,917 | 17.61 | |
548,442 | 2,598,332 | 21.11 | |
(click for more detail) |
Financial data and stock pages provided by
Fintel.io